National Eczema Association is located in Novato, CA. The organization was established in 1993. According to its NTEE Classification (O40) the organization is classified as: Scouting, under the broad grouping of Youth Development and related organizations. As of 12/2023, National Eczema Association employed 33 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. National Eczema Association is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, National Eczema Association generated $7.2m in total revenue. This organization has experienced exceptional growth, as over the past 4 years, it has increased revenue by an average of 14.9% each year . All expenses for the organization totaled $8.1m during the year ending 12/2023. While expenses have increased by 23.9% per year over the past 4 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2020, National Eczema Association has awarded 33 individual grants totaling $1,149,067. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990T
Mission & Program ActivityExcerpts From the 990T Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
NEA IS THE DRIVING FORCE FOR AN ECZEMA COMMUNITY FUELED BY KNOWLEDGE, STRENGTHENED THROUGH COLLECTIVE ACTION AND PROPELLED BY THE PROMISE OF A BETTER FUTURE.
Describe the Organization's Program Activity:
ECZEMA RESEARCH WE DONEAS RESEARCH TEAM SEEKS TO UNDERSTAND THE UNIQUE EXPERIENCES OF PEOPLE WITH ECZEMA. IN 2023, WE LAUNCHED A SURVEY TO LEARN ABOUT THE BURDEN AND UNMET NEEDS FOR TYPES OF ECZEMA OTHER THAN ATOPIC DERMATITIS. IT IS OUR HOPE THAT THIS NEW DATA WILL LEAD TO BETTER CARE AND SUPPORT.ECZEMA EXPO 2023 IN ORLANDO, FL ECZEMA EXPO IS OUR ANNUAL CONFERENCE AND OUR FAVORITE WEEKEND OF THE YEAR! WE WELCOMED MORE THAN 350 COMMUNITY MEMBERS TO EXPO IN JUNE 2023. THEY LEARNED FROM WORLD-CLASS EXPERTS, PHYSICIANS AND RESEARCHERS ABOUT THE LATEST IN ECZEMA RESEARCH AND DRUG DEVELOPMENT. THEY ALSO BONDED OVER SHARED STORIES AND CREATED A COMMUNITY OF SUPPORT AND CONNECTION. SURVEY RESULTS SHOWED THAT 88% OF ATTENDEES FELT MORE CONNECTED TO THE ECZEMA COMMUNITY. WERE EXCITED ABOUT ECZEMA EXPO IN DENVER, CO, FROM JUNE 2730, 2024.SEAL OF ACCEPTANCE ADDS TWO NEW CATEGORIESNEAS SEAL OF ACCEPTANCE IS AN EMBLEM THAT CERTIFIES THAT A PRODUCT HAS UNDERGONE RIGOROUS TESTING AND SCIENTIFIC REVIEW WHERE ITS INGREDIENTS AND FORMULATION DATA MEET SEAL STANDARDS FOR SENSITIVITY, IRRITATION AND TOXICITY. PEOPLE WITH ECZEMA RELY ON THE SEAL TO HELP INFORM THEIR CHOICE OF PERSONAL CARE AND HOUSEHOLD PRODUCTS. NEA RECENTLY ADDED LIP CARE AND DEODORANT CATEGORIES TO BETTER HELP OUR COMMUNITY LIVE WELL WITH ECZEMA.NEA AMBASSADORS TAKE ACTIONLAST YEAR, NEA AMBASSADORS PARTICIPATED IN NEARLY 200 ADVOCACY, RESEARCH OR AWARENESS EVENTS. THEY SHARED THEIR STORIES WITH STAFF AT MORE THAN 100 LEGISLATIVE OFFICES AND ASKED FOR SUPPORT OF THE SAFE STEP ACT AND THE HELP COPAYS ACT, WHICH ADVOCATE FOR BETTER ACCESS TO ECZEMA CARE. THEIR EFFORTS RESULTED IN SIX NEW COSPONSORS FOR THESE ACTS.ECZEMAWISEECZEMAWISE IS THE FREE ECZEMA TRACKER APP TO HELP MANAGE ECZEMA BETWEEN DOCTOR VISITS. FOR THE SECOND YEAR, ECZEMAWISE RECEIVED MULTIPLE TOP PRIZES FROM THE EHEALTHCARE LEADERSHIP AWARDS. ECZEMAWISE RECEIVED THE SILVER PRIZE FOR BEST MOBILE APP, BEST CARE/DISEASE MANAGEMENT AND BEST EMAIL CONTENT.ECZEMA AWARENESS MONTH 2023FOR ECZEMA AWARENESS MONTH, NEA FEATURED STORIES FROM PEOPLE WITH ECZEMA ON A BILLBOARD IN THE FAMOUS TIMES SQUARE IN NEW YORK CITY! THESE STORIES AND MORE WERE FEATURED IN OUR #ONETHINGABOUTECZEMA SOCIAL MEDIA CAMPAIGN. THESE POSTS AND VIDEOS RECEIVED NEARLY 5 MILLION IMPRESSIONS AND RESULTED IN GREATER AWARENESS OF ECZEMA.
ECZEMA RESEARCH WE FUNDLAST YEAR, NEA CELEBRATED THE 20TH ANNIVERSARY OF OUR RESEARCH PROGRAM BY AWARDING NEARLY $1 MILLION IN GRANTS TO ECZEMA RESEARCHERS. THEIR RESEARCH WILL EXPLORE THE MANY FACETS OF ECZEMA, INCLUDING THE SCIENCE BEHIND ITCH AND INFLAMMATION, PSYCHOSOCIAL BURDEN AND NEW PATHWAYS FOR POTENTIAL THERAPIES.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Julie Block CEO | 40 | $298,000 | |
Wendy Smith Begolka VP Scientific Affr | 40 | $219,167 | |
Scott Sanford COO | 40 | $206,000 | |
Amber Whiteside Dir Mkting & Com | 40 | $180,083 | |
Melody Sugg VP Philanthropy | 40 | $184,000 | |
Christina Crowley Chairwoman | OfficerTrustee | 2 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Unosquare Llc Software Dev | 12/30/23 | $509,086 |
Hida Visuals Video Production | 12/30/23 | $150,311 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $3,748,923 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $3,748,923 |
Total Program Service Revenue | $3,635,456 |
Investment income | $144,137 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | -$317,435 |
Net Income from Fundraising Events | $1,045 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $7,212,126 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $317,020 |
Grants and other assistance to domestic individuals. | $82,622 |
Grants and other assistance to Foreign Orgs/Individuals | $216,459 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $599,119 |
Compensation of current officers, directors, key employees. | $38,795 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $2,916,312 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $610,011 |
Payroll taxes | $248,055 |
Fees for services: Management | $0 |
Fees for services: Legal | $16,605 |
Fees for services: Accounting | $96,741 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $90,671 |
Advertising and promotion | $0 |
Office expenses | $42,007 |
Information technology | $265,322 |
Royalties | $0 |
Occupancy | $142,447 |
Travel | $152,316 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $396,162 |
Insurance | $22,567 |
All other expenses | $190,490 |
Total functional expenses | $8,122,529 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $1,407,818 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $631,090 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $68 |
Net Land, buildings, and equipment | $254,703 |
Investments—publicly traded securities | $4,971,923 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $1,632,996 |
Other assets | $11,600 |
Total assets | $8,910,198 |
Accounts payable and accrued expenses | $71,748 |
Grants payable | $0 |
Deferred revenue | $50,000 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $276,131 |
Total liabilities | $397,879 |
Net assets without donor restrictions | $8,352,599 |
Net assets with donor restrictions | $159,720 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $8,910,198 |
Over the last fiscal year, National Eczema Association has awarded $307,035 in support to 8 organizations.
Grant Recipient | Amount |
---|---|
BOSTON CHILDRENS HOSPITAL PURPOSE: Research | $31,903 |
EMORY UNIVERSITY PURPOSE: Research | $66,666 |
MA GENERAL HOSPITAL PURPOSE: Research | $50,002 |
UC SAN DIEGO PURPOSE: Research | $50,001 |
PHOENIX CHILDRENS HOSPITAL PURPOSE: Research | $16,667 |
UC SAN FRANCISCO PURPOSE: Research | $66,624 |